Deficiency Index

Amedicus Hospice Inc

Dallas, Texas · CCN 741799

10935 Estate Lane, Suite 320

33 federal deficiencies across 3 surveys, May 25, 2022 to July 3, 2025.

Deficiencies33

Excludes the inspector’s preamble, which is not a finding

Surveys3

Federal surveys with at least one deficiency

Condition-level2

Findings against a Condition of Participation — a compliance grade, not a measure of harm

What level the findings sit at

Condition-level26.1%
The agency was out of compliance with a federal Condition of Participation — a requirement it must meet to take part in Medicare at all.
Standard-level3193.9%
A requirement within a Condition of Participation. The Condition itself was not cited.

These are compliance grades, not harm grades: how deep in the regulation a finding sits, not whether anyone was harmed.

Who conducted the surveys

ACHC.

Federal surveys are carried out by the state agency or a CMS-approved accrediting organisation.

Most-cited requirements

Survey record

Federal surveys of Amedicus Hospice Inc
SurveyTypeDeficienciesCondition-level
Jul 3, 2025Follow-Up2—
May 15, 2025Reaccreditation252
May 25, 2022Reaccreditation6—

In the inspector’s words

The complete written findings for this hospice, in the inspector’s own words.

Read all 33 findings in full →

Hospice findings published by CMS on QCOR, covering surveys from May 25, 2022 to July 3, 2025. The inspectors’ written findings come from a single CMS survey-report extract.

Federal survey findings only. State licensure findings for hospices are not shown.

Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction